Search

everythinglearnresearchcommunity

for

Search:↓

TrichoFoam™ is a stable option for personalized hair loss treatment with most ingredients remaining effective for 90-180 days.

CTHRC1 is essential for healing and preventing heart rupture after a heart attack.

Steroids may not work well for alopecia areata because of high unoccupied receptors and low thioredoxin levels.

Oral valganciclovir improved a patient's skin condition caused by immunosuppression.

Vitamin D3 and its receptor help protect skin from UVB-related cancer.

Transglutaminase activity is important for skin and is found in both mammals and birds.

Mice genetically modified to produce more CD109 in their skin had less inflammation and better healing with less scarring.

Green tea component EGCG may help prevent hair loss by changing microRNA levels in certain scalp cells.

Trichoriboside treatment helps maintain scalp hair by increasing cAMP levels in hair follicles of men with hair loss.

TDM10842, a thyroid hormone receptor activator, was found to effectively promote hair growth in mice.

All-trans retinoic acid causes hair loss by increasing TGF-β2 in hair follicle cells.

Hydroxytyrosol helps reduce liver injury by blocking certain inflammation pathways.

Special immune cells called Tregs can help prevent lung scarring by blocking a specific growth factor.

Green tea component EGCG helps keep rat skin grafts viable longer.

Oral tofacitinib helped regrow hair in over half of the patients with severe alopecia, but relapses and side effects were common.

Alopecia areata patients have lower zinc, copper, and selenium levels than healthy people.

A hair tightly wrapped around a toddler's toe caused severe crying and was treated by surgery.

Janus kinase inhibitors show promise in treating alopecia areata but need more safety research.

Photodynamic therapy may not work for erythroplasia of Queyrat and could lead to invasive squamous cell carcinoma.

Aleglitazar and its major metabolite are safe enough to proceed to Phase 3 clinical trials.

Tofacitinib, a JAK inhibitor, improved hair regrowth in most patients with severe alopecia areata and had minimal side effects.

Changing neuroactive steroids in baby male rats affects their memory and learning differently as they grow up.

The type of PCOS a woman has doesn't strongly predict her skin or metabolic symptoms; obesity is a more important factor.

Tofacitinib is a potential alternative treatment for alopecia totalis, especially in patients with a shorter duration of the condition and more preserved hair follicles, but the overall response rate is low.

The document explains how male reproductive hormones work and affect the body.

PDE inhibitors, especially PDE4 inhibitors like apremilast, are effective for certain inflammatory skin conditions but have side effects and can be costly.

Hair loss in Lichen Planopilaris is caused by immune system issues damaging hair follicles and stem cells.

Skin symptoms can indicate endocrine disorders and have various treatments.

A boy on a ketogenic diet and anti-epileptic drugs developed skin issues due to stopping vitamin supplements, which improved with proper supplementation.

A new method can almost perfectly distinguish adenomyosis from similar conditions using blood tests.